Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 3 February 2006. doi:10.1136/jcp.2005.027722
Journal of Clinical Pathology 2006;59:367-372
Copyright © 2006 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

ORIGINAL ARTICLE

Frequent 7q gains in flow cytometric multiploid/hypertetraploid breast carcinomas: a study of chromosome imbalances by comparative genomic hybridisation

A E Pinto1, L Roque2, R Rodrigues2, S André1 and J Soares1

1 Department of Pathology, CROL, SA, Lisbon, Portugal
2 Cytogenetic Laboratory of Molecular Pathobiology Research Centre (CIPM) of Portuguese Cancer Institute, CROL, SA, Lisbon

Correspondence to:
Correspondence to:
Dr António E Pinto
Departamento de Patologia Morfológica, Instituto Português de Oncologia, CROL, SA, R Prof Lima Basto, 1099-023 Lisbon, Portugal; aepinto{at}ipolisboa.min-saude.pt

Objective: To investigate underlying genetic events associated with complex DNA ploidy breast carcinomas.

Methods: Screening for chromosome imbalances was carried out using comparative genomic hybridisation (CGH) in 14 frozen samples of tumour from a series of 13 breast cancer patients with multiploid (n = 11) and hypertetraploid (n = 2) tumours. They had previously been analysed by DNA flow cytometry and also assessed immunohistochemically for p53 tissue expression. Ploidy status was determined on frozen samples using the Multicycle software program.

Results: The total number of copy gains (n = 242) was significantly greater than the number of copy losses (n = 51). The mean (SD) number of gains per sample was 17.3 (5.7), and of losses, 3.6 (4.2) (p = 0.0001). Gains of chromosomal regions at 1q (14/14; 100%), 7q (12/14; 85.7%), and 3q (11/14; 78.6%), as well as 1p, 2q, 5p, 8q, and 13q (10/14; 71.4%) were the most frequent aberrations in this series. Losses were most commonly found on 17p (5/14; 35.7%). Three patients dying of the disease had tumours with high level amplifications at 1q12-qter, 3q22–q25, and 8q22–q23 regions. Six cases had p53 overexpression, of whom four showed 12q gains and two showed 17p losses.

Conclusions: There is a very high incidence of genetic aberrations, mainly related to chromosomal gains, in this subgroup of aneuploid breast cancer patients, associated with a poor clinical outcome. The 7q locus, not previously reported as showing frequent changes in breast cancer, was found to be a potential site for some candidate oncogenes.

Abbreviations: CGH, comparative genomic hybridisation; DI, DNA index; FCM, flow cytometry; TNM, "tumour, node, metastasis" classification; UICC, International Union Against Cancer

Keywords: breast cancer; DNA flow cytometry; comparative genomic hybridisation; multiploid/hypertetraploid tumours


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Savage, K., Lambros, M. B.K., Robertson, D., Jones, R. L., Jones, C., Mackay, A., James, M., Hornick, J. L., Pereira, E. M., Milanezi, F., Fletcher, C. D.M., Schmitt, F. C., Ashworth, A., Reis-Filho, J. S. (2007). Caveolin 1 Is Overexpressed and Amplified in a Subset of Basal-like and Metaplastic Breast Carcinomas: A Morphologic, Ultrastructural, Immunohistochemical, and In situ Hybridization Analysis. Clin. Cancer Res. 13: 90-101 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs